Cellumed Co., Ltd., headquartered in South Korea (KR), is a leading player in the biotechnology industry, specialising in innovative regenerative medicine solutions. Founded in 2001, the company has made significant strides in developing advanced cell therapies and biomaterials, positioning itself as a pioneer in the field. With a focus on skin regeneration and wound healing, Cellumed offers unique products such as its proprietary cell-based therapies that stand out for their efficacy and safety. The company has established a strong presence not only in the domestic market but also in key international regions, enhancing its global footprint. Recognised for its commitment to research and development, Cellumed has achieved notable milestones, including collaborations with prestigious institutions and successful clinical trials. This dedication to innovation solidifies its market position as a trusted provider of cutting-edge medical solutions.
How does Cellumed Co.,Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Cellumed Co.,Ltd.'s score of 22 is lower than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Cellumed Co., Ltd., headquartered in South Korea (KR), currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges available from the company. As a result, Cellumed's climate commitments and initiatives remain unclear, and there is no inherited emissions data from a parent or related organization. The company may still be in the process of developing its sustainability strategies or reporting frameworks. In the context of the industry, it is essential for companies like Cellumed to establish clear climate commitments and reduction targets to align with global sustainability goals and enhance their environmental accountability.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Cellumed Co.,Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

